306271-94-3

Basic information

• Product Name: 3'',3'''-dichloro-5'',5'''-di(methoxycarbonyl)-4'',4'''-di[p-[(methoxycarbonyl)methyl]benzyloxy]-4',4'-diphenyl-3β-(3'-buten-1'-yl)cholestane
• Synonyms: 3'',3'''-dichloro-5'',5'''-di(methoxycarbonyl)-4'',4'''-di[p-[(methoxycarbonyl)methyl]benzyloxy]-4',4'-diphenyl-3β-(3'-buten-1'-yl)cholestane
• CAS NO: 306271-94-3
• Molecular Weight: 1120.3
• Mol File: 306271-94-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 3'',3'''-dichloro-5'',5'''-di(methoxycarbonyl)-4'',4'''-di[p-[(methoxycarbonyl)methyl]benzyloxy]-4',4'-diphenyl-3β-(3'-buten-1'-yl)cholestane(CAS DataBase Reference)
• NIST Chemistry Reference: 3'',3'''-dichloro-5'',5'''-di(methoxycarbonyl)-4'',4'''-di[p-[(methoxycarbonyl)methyl]benzyloxy]-4',4'-diphenyl-3β-(3'-buten-1'-yl)cholestane(306271-94-3)
• EPA Substance Registry System: 3'',3'''-dichloro-5'',5'''-di(methoxycarbonyl)-4'',4'''-di[p-[(methoxycarbonyl)methyl]benzyloxy]-4',4'-diphenyl-3β-(3'-buten-1'-yl)cholestane(306271-94-3)

Safety Data

• Hazardous Substances Data: 306271-94-3(Hazardous Substances Data)

Upstream product

• 154212-56-3 cosalane 
• 13737-36-5 4-bromophenylacetic acid 
• 7398-42-7 methyl 2-(4-(bromomethyl)phenyl)acetate 
• 306271-95-4 cosalane dimethyl ester 

Relevant articles and documents

Correlation of anti-HIV activity with anion spacing in a series of cosalane analogues with extended polycarboxylate pharmacophores

Cosalane and its synthetic derivatives inhibit the binding of gp120 to CD4 as well as the fusion of the viral envelope with the cell membrane. The binding of the cosalanes to CD4 is proposed to involve ionic interactions of the negatively charged carboxylates of the ligands with positively charged arginine and lysine amino acid side chains of the protein. To investigate the effect of anion spacing on anti-HIV activity in the cosalane system, a series of cosalane tetracarboxylates was synthesized in which the two proximal and two distal carboxylates are separated by 6-12 atoms. Maximum activity was observed when the proximal and distal carboxylates are separated by 8 atoms. In a series of cosalane amino acid derivatives containing glutamic acid, glycine, aspartic acid, β-alanine, leucine, and phenylalanine residues, maximum activity was displayed by the di(glutamic acid) analogue. A hypothetical model has been devised for the binding of the cosalane di(glutamic acid) conjugate to CD4. In general, the compounds in this series are more potent against HIV-1RF in CEM-SS cells than they are vs HIV-1IIIB in MT-4 cells, and they are least potent vs HIV-2ROD in MT-4 cells.